GLIBA vs META
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GLIBA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the company maintains a strong liquidity position with a current ratio of 3.14 and trades at a discount to book value (P/B 0.85), these are offset by negative net profit margins (-29.54%) and stagnant revenue growth. A significant earnings miss of 66% in the most recent reported quarter further underscores the disconnect between current performance and the optimistic single-analyst target price of $68.00.
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
Compare Another Pair
Related Comparisons
GLIBA vs META: Head-to-Head Comparison
This page compares GCI Liberty, Inc. - Series A GC (GLIBA) and Meta Platforms, Inc. (META) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.